Kranium Biotech is a boundary-pushing biotech company focused on unlocking the full potential of the human brain. Blending neuroscience, synthetic biology, and AI, Kranium develops cutting-edge therapies and neurotech platforms aimed at enhancing cognition, treating neurological disorders, and bridging biology with machine intelligence.